Advice
Following a full submission
dibotermin alfa (InductOs) is accepted for restricted use within NHS Scotland for the treatment of acute tibia fractures in adults, as an adjunct to standard care using open fracture reduction and intramedullary nail fixation in patients in whom there is a substantial risk of non-union.
It is restricted to patients treated with unreamed intramedullary nails. Cost effectiveness has only been shown in Gustilo-Anderson Grade IIIB fractures.
Download detailed advice49KB (PDF)
Medicine details
- Medicine name:
- dibotermin alfa (InductOs)
- SMC ID:
- 365/07
- Indication:
- Acute tibia fractures in adults
- Pharmaceutical company
- Medtronic
- BNF chapter
- Musculoskeletal and joint diseases
- Submission type
- Full
- Status
- Restricted
- Date advice published
- 07 May 2007